Latest Articles
Most elderly patients with subclinical hypothyroidism do not need to be treatedAge-adjusted thyrotropin reference ranges, consideration of individual circumstances, and a wait-and-see approach for mild subclinical hypothyroidism might be more suitable than a universal treatment strategy.
- Psychedelics in the medical toolbox?
Given the historical association of psychedelics as “recreational” mind-altering compounds within countercultures of the 1960s and 1970s, their current introduction into several aspects of medical practice is a surprise to many.
- Should glucagon-like peptide 1 receptor agonists be withheld during the preoperative period?
Clinical judgment should guide this decision, taking into account patient symptoms and the presence of factors that may delay gastric emptying and increase risk for aspiration.
- Subclinical hypothyroidism: What’s in a name?
Clinicians should remain thoughtful about the variability in aging biology and not be blinded by a name.
- Psychedelics, spirituality, and existential distress in patients at the end of life
The authors explore the role of psychedelics in addressing patients’ spiritual and existential suffering at the end of life from a medical, ethical, and legal perspective.
- Coronary artery bypass grafting: Practice trends and projections
Future directions include expanding the use of multiarterial grafting, offering patients less-invasive approaches, and enhancing operative recovery.
- Can my patient with a ‘sulfa allergy’ receive celecoxib or other nonantimicrobial sulfonamides?
There is no cross-reactivity between antimicrobial and nonantimicrobial sulfonamides, and patients with a history of immunoglobulin E–mediated reaction to a sulfonamide antibiotic can receive nonantimicrobial sulfonamides.
